Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ENTXENTX
22 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ENTERA BIO LTD

Yes. Citadel Advisors holds 38,804 shares of ENTX (Entera Bio), worth $68,683, as of its Q2 2026 13F filing. It reduced the position by 206,773 shares (-84.2%) from Q1 2026. Citadel Advisors has held ENTX since Q2 2025, across 5 quarterly 13F filings.

Current Value

$68,683

Current Shares

38,804

Total Value Change

+$40,683

Total Shares Change

+16,784

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
38,804
-84.2%
$68,6830.0%$1.77
0
2026-Q1
Increased
245,577
+510.4%
$272,5900.0%$1.11
26
2025-Q4
Increased
40,230
+0.6%
$78,0460.0%$1.94
15
2025-Q3
Increased
39,978
+243.0%
$76,7580.0%$1.92
23
2025-Q2
New
11,656
-
$22,1460.0%$1.90
29
2024-Q4
Exited
0
-100.0%
$00.0%$2.12
0
2024-Q3
New
20,553
-
$39,0510.0%$1.90
31
2024-Q2
Exited
0
-100.0%
$00.0%$1.84
0
2024-Q1
New
12,502
-
$20,8780.0%$1.67
29
2023-Q4
Exited
0
-100.0%
$00.0%$0.60
0
2023-Q3
Increased
15,368
+479x
$11,1420.0%$0.73
19
2023-Q2
New
32
-
$270.0%$0.84
17
2023-Q1
Exited
0
-100.0%
$00.0%$1.16
0
2022-Q4
New
30,465
-
$22,2390.0%$0.73
29
2022-Q3
Exited
0
-100.0%
$00.0%$1.04
0
2022-Q2
Decreased
12,657
-15.9%
$17,0000.0%$1.33
0
2022-Q1
Decreased
15,057
-45.4%
$43,0000.0%$2.87
0
2021-Q4
Decreased
27,588
-30.8%
$78,0000.0%$2.82
0
2021-Q3
Decreased
39,858
-40.7%
$188,0000.0%$4.71
0
2021-Q2
New
67,170
-
$402,0000.0%$5.98
33
2020-Q4
Exited
0
-100.0%
$00.0%$1.08
0
2020-Q3
New
22,020
-
$28,0000.0%$1.24
30

Other major holders of ENTX: RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used